High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$109K
$109,506
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VIR
S
Vir Biotechnology, Inc.
Sabatini Brent
• Officer • SVP, Chief Accounting Officer
10b5-1 SellΔOwn -11.1%
2026-03-23
$70,324
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • SVP, Chief Accounting Officer
10b5-1 SellΔOwn -11.1%
|
2026-03-23 | $70,324 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
Sabatini Brent
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-02-24
$13,632
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-02-24 | $13,632 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
Sabatini Brent
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-02-23
$13,631
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-02-23 | $13,631 | S | Form 4 |
|
VIR
S
Vir Biotechnology, Inc.
Sabatini Brent
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-02-13
$11,919
|
||||||
| VIR |
Vir Biotechnology, Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-02-13 | $11,919 | S | Form 4 |